Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

29.42
BATS BZX Real-Time Price
As of 3:27pm ET
 -0.46 / -1.54%
Today’s Change
29.42
Today|||52-Week Range
56.44
-18.84%
Year-to-Date
Amgen (AMGN) Submits BLA to FDA for Migraine Drug Erenumab
May 19 / Zacks.com - Paid Partner Content
Teva (TEVA) Q1 Earnings In Line, Sales Lag as Copaxone Falls
May 12 / Zacks.com - Paid Partner Content
Valeant (VRX) Decides to Extend Stay on Xifaxan's ANDA
May 19 / Zacks.com - Paid Partner Content
Impax (IPXL) Q1 Earnings Miss, Stock Up on Cost Savings Plan
May 11 / Zacks.com - Paid Partner Content
Teva Pharmaceutical Leaning Towards Foreigner as New CEO
May 18 / TheStreet.com - Paid Partner Content
Teva (TEVA) Q1 Earnings In-Line, Sales Miss, Shares Up
May 11 / Zacks.com - Paid Partner Content
Francis Chou Buys Pharmaceutical Stocks, Including Valeant
May 17 / GuruFocus News - Paid Partner Content
Mylan vs. Teva: Which Is the Better Generics Stock Ahead of Earnings?
May 09 / Zacks.com - Paid Partner Content
Vanguard Health Care Fund Buys Abbott Laboratories, Tesaro Inc, Teva Pharmaceutical I...
May 16 / GuruFocus News - Paid Partner Content
Allergan (AGN) Beats Q1 Earnings Estimates, Ups 2017 View
May 09 / Zacks.com - Paid Partner Content
Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka
May 16 / Zacks.com - Paid Partner Content
Teva Pharmaceutical (TEVA) Q1 Earnings: What's in the Cards?
May 08 / Zacks.com - Paid Partner Content
Lilly's Migraine Drug Phase III Trials Meet Primary Endpoint
May 15 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Merck, Pfizer Report Q1 Earnings, J&J Talc Powder Lawsuit
May 08 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Mylan, Teva Q1 Earnings, Roche Drug Misses in Pivotal Study
May 12 / Zacks.com - Paid Partner Content